Moderna earnings come in far short of estimates

0
78

Moderna Inc.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleWrangler, Lee jeans parent Kontoor Brands reports earnings beat, raises full-year outlook
Next articleReal Retirement: Dr. Ruth says sex can still be a joy when you’re older

LEAVE A REPLY

Please enter your comment!
Please enter your name here